TGFBR2 and neoplasm: To confirm this in vivo, TβRII WT or CD8 TβRII KO mice were inoculated with KPC3.TRP1 tumor cells and received Reo&CD3-bsAb therapy as described earlier (Supplementary Fig. S5C).